Skip to Main Content
Steven Kliewer, Ph.D.

Steven Kliewer, Ph.D.

Titles and Appointments

Professor

Endowed Title
Diana K. and Richard C. Strauss Distinguished Chair in Developmental Biology
School
Medical School
Department
Molecular Biology | Pharmacology
Graduate Programs
Cell and Molecular Biology
  • Biography

    Steven Kliewer earned his BS in biochemistry from Brown University in 1985 and his PhD in molecular biology from UCLA in 1990. From 1990-1993, he was a postdoctoral fellow at the Salk Institute, and from 1993-2002 he was a scientist at GlaxoSmithKline, rising to Director of Nuclear Receptor Research.  In 2002, he joined UT Southwestern, where he is currently Professor of Molecular Biology and Pharmacology and holds the Diana K. and Richard C. Strauss Distinguished Chair in Developmental Biology.  He is a member of the National Academy of Sciences.

    Dr. Kliewer runs a joint laboratory with Dr. David Mangelsdorf.  Their research focuses on the roles of nuclear receptors and endocrine FGFs in regulating diverse aspects of physiology and pathophysiology, including metabolism and related diseases.  Among their ongoing projects, they are studying how FGF19 and FGF21 regulate bile acid and energy homeostasis, respectively, and how the dafachronic acid receptor, DAF-12, regulates the infectious lifecycle of parasitic nematodes.